[Anticoagulation in atrial fibrillation: not yet settled].
A great deal of interest has received atrial fibrillation, the most common arrhythmia in adults, due to its complications and difficult treatment its most dreaded complication is atrial thrombi formation with the subsequent risk of embolization. There are several reports defining risk factors for embolic complications and the usefulness of anticoagulants for their prevention. We review the state of the art of anticoagulation in atrial fibrillation not associated to rheumatic valvulopathy. We also give tools to assess embolic risk and to determine the anticoagulant choice for the different presentation forms of atrial fibrillation.
Montagna
R
R
Centro Nacional de Arritmias, Hospital Clínico Universidad de Chile, Santiago, Chile.
Asenjo
R
R
Madariaga
R
R
D000367:Age Factors; D000925:Anticoagulants / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000517:prevention & control; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004554:Electric Countershock; D006801:Humans; D015201:Meta-Analysis as Topic; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants
Tratamiento anticoagulante en fibrilación auricular: aún no está todo resuelto.